How Pharma Can Close the Gap Between Prescription and Therapy — FieldOS Live in TheyDo

Watch the system that governs progression from prescribing intent to initiated and sustained therapy.

See journey operations in practice.

Wayne Simmons, creator of the FieldOS methodology and former Global Head of Customer Excellence at Pfizer, joins TheyDo CEO Jochem van der Veer for a live session on what it actually takes to govern progression from prescribing intent to initiated and sustained therapy.

Up to 50% of written specialty prescriptions never convert into initiated therapy. The failure is not clinical. It is structural.

Reimbursement variability, prior authorization, affordability barriers, and fragmented handoffs across field, hub, and patient services compound into a system that leaks value at every stage. Compounded across fulfillment, initiation, and adherence, $1 billion in earned value becomes roughly $450 million realized.

In this live session, Wayne and Jochem move from diagnosis to demonstration. Using the FieldOS reference architecture inside TheyDo, they'll show how pharma commercial teams can make progression visible, measurable, and governable — across the path to prescribe, fulfill, and adhere.

Join us for a working session built around the commercial problem.

What you'll see

• The Value Leakage Ladder: how compounding drop-off turns $1B in earned value into ~$450M realized — and where the structural fix begins

• FieldOS in TheyDo: a live demonstration of journey operations governing progression across prescribing, fulfillment, and adherence

• What changes when the downstream system becomes observable: for field teams, management reviews, and revenue forecasting

• How to identify where your commercial architecture is leaking value today

Read the whitepaper. Now see the system in action.

Who this is for

This session is built for senior pharma commercial leaders who own the system between prescribing intent and therapy realization — VPs and Directors of Commercial Operations, Field Effectiveness, Commercial Excellence, and Field Sales. Brand GMs accountable for therapy initiation and persistence, and CCOs focused on experience governance and downstream conversion, will find equal relevance.

Join us live

Can't make it live? Register anyway and we'll send you the recording.